Ambispective Registry of Patients Affected by Lung Cancer

Lung cancer is one of the most common cancers and the leading cause of cancer-related death. It is often diagnosed late, and there are different types of lung cancer. Today, many patients benefit from targeted therapies and immunotherapy, which have improved survival. This study will create an ambispective clinical registry of all lung cancer patients treated at Policlinico San Matteo. The registry will collect data from 2019 to 2035 to better understand: 10-year overall survival, how the disease progresses over time, how patients respond to treatments and possible side effects, how patient and tumor characteristics influence treatment choices, how different therapies work in real-world practice. All data will be securely collected whithin REDCap platform and used to improve future care and research.

NCT Number	NCT07274163
Lead Sponsor	Fondazione IRCCS Policlinico San Matteo di Pavia
Conditions	Lung Cancer
Enrollment	1,500 participants
Start Date	2019-01-01
Primary Completion	2035-12 (estimated)
Study Completion	2035-12 (estimated)
Updated on ClinicalTrials.gov	2025-12-24